Catalyst Wire Dossier Catalyst Wire Dossier

MOXIFLOXACIN HYDROCHLORIDE TABLETS, 400 MG

moxifloxacin hydrochloride · Novadoz Pharmaceuticals LLC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MOXIFLOXACIN HYDROCHLORIDE TABLETS, 400 MG, covering 2017-09-22 to 2020-06-03. Get the full timeline:

Most recent: FDA Approved: MOXIFLOXACIN HYDROCHLORIDE TABLETS, 400 MG — Supplemental Application (Novadoz Pharmaceuticals LLC)

See pricing